Current NDC auxiliary source row compounder:73

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 70092-290
Product Ndc: 70092-290
Product Ndc Digits: 70092290
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Hydromorph PF 0.5 mg/ml 30ml NS-35 ml MB
Proprietary Name Suffix: [empty]
Nonproprietary Name: Hydromorph PF 0.5 mg/ml 30ml NS-35 ml MB
Dosage Form Name: INJECTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: QuVa Pharma, Inc.
Establishment Name: QuVa Pharma, Inc.
Establishment Fei: [empty]
Substance Name: HYDROMORPHONE HYDROCHLORIDE
Active Ingredients Info: 15 mg/30 mL
History Active Ingredients Raw: HYDROMORPHONE HYDROCHLORIDE
History Active Ingredients Info Raw: 15 mg/30 mL
History Dosage Raw: INJECTION
Dea Schedule: CII
Package Ndc Raw: 70092-290-49
Package Ndc: 70092-290-49
Package Ndc Digits: 7009229049
Package Ndc11: 70092029049
Package Description: 30 mL in 1 SYRINGE (70092-290-49)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:73
Source Row Number: 73
Source Row Hash: 8a6971dbc59b5c656d4a28516aba62186b557b8d5b6300d9f6826c193e9da32d
Import Run Id: 20261015T130142Z
Loaded At: 2026-10-15 13:06:14

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "70092-290",
    "DEASCHEDULE": "CII",
    "LABELERNAME": "QuVa Pharma, Inc.",
    "SUBSTANCENAME": "HYDROMORPHONE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "70092-290-49",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Hydromorph PF 0.5 mg/ml 30ml NS-35 ml MB",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Hydromorph PF 0.5 mg/ml 30ml NS-35 ml MB",
    "PACKAGEDESCRIPTION": "30 mL in 1 SYRINGE (70092-290-49) ",
    "ACTIVEINGREDIENTSINFO": "15 mg/30 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:73
Source Row Number: 73
Status Scope: package
Lookup Ndc: 70092-290-49
Lookup Ndc Digits: 7009229049
Product Ndc: 70092-290
Product Ndc Digits: 70092290
Package Ndc: 70092-290-49
Package Ndc Digits: 7009229049
Package Ndc11: 70092029049
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 8a6971dbc59b5c656d4a28516aba62186b557b8d5b6300d9f6826c193e9da32d
Import Run Id: 20261015T130142Z
Loaded At: 2026-10-15 13:06:14